All stock lists
Brookfield Wealth Solutions Ltd (New York Stock Exchange:BNT)
BM · Delayed Price · Currency is USD
Also listed: BNT.TOFinancial Services · Insurance - Diversified
42.07-0.25 (-0.59%)
Market cap
$14.0B
Insider Score
Health Score
Listed since
Jun 28, 2021
Website
Insider Score
––Not scored
BNT Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From BNT’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability11 / 20
Profitable, but on a thin margin.
- Revenue
- $11.95B
- Net income
- $129.9M
- Net margin
- 1.1%
Leverage20 / 20
Little or no net debt.
- Total debt
- $9.62B
- Cash
- $13.21B
- Net debt / EBITDA
- -3.74x
Liquidity—
Current assets or liabilities not reported.
- Current assets
- $13.21B
- Current liabilities
- $0
- Current ratio
- —
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $3.32B
- Free cash flow
- $3.25B
- FCF margin
- 27.2%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 357.6M
- Share growth (1y)
- 47.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BNT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $4.11 B | $1.63 B | $3.10 B | $3.11 B | $2.91 B | $2.42 B |
| Revenue Growth (YoY) | 41.43 % | -32.46 % | -48.15 % | 13.13 % | -0.31 % | -4.39 % |
| Cost of Revenue | $0.00 | $645.93 M | $1.58 B | $1.97 B | $1.89 B | $2.33 B |
| Gross Profit | $4.11 B | $987.13 M | $1.52 B | $1.14 B | $1.01 B | $86.00 M |
| SG&A Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $3.93 B | $1.62 B | $1.55 B | $384.00 M | $405.00 M | $455.00 M |
| Operating Income | $179.33 M | -$633.11 M | -$28.43 M | $757.00 M | $607.00 M | -$369.00 M |
| Pretax Income | $179.33 M | -$633.11 M | -$28.43 M | $757.00 M | $607.00 M | -$369.00 M |
| Tax Provision | $34.11 M | -$39.45 M | -$49.75 M | $149.00 M | $91.00 M | -$87.00 M |
| Net Income | $139.37 M | -$600.56 M | $8.12 M | $583.00 M | $501.00 M | -$326.00 M |
| EPS (Basic) | $0.38 | -$2.25 | $0.01 | $1.91 | $1.76 | -$1.34 |
| EPS (Diluted) | $0.38 | -$2.25 | $0.01 | $1.91 | $1.76 | -$1.34 |
| Shares Outstanding | 357.59 M | 272.69 M | 304.93 M | 304.93 M | 242.51 M | 242.59 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.